OCFN is a take over target and would not be around in

New Post Public Reply Private Reply Replies (0) Message Board
Jack30
OCFN is a take over target and would not be around in couple of months, max. It has 180 million assets compare to it's 8 million market cap. It's also profitable and should not be this low. Just look at FNMA or FMCC, where they were couple of years ago and where they are now.

Omega Commercial Finance Corporation a Dynamic Company Primed For Success in the Small Cap Growth Sector Offers Quick Facts

7:30 AM ET 11/6/13 | Marketwire

Omega Commercial Finance Corporation (OTCQB: OCFN) a publicly traded financial holding company believes there is a remarkable amount of opportunities onward extending into next year and well into the next decade. Here are some QUICK FACTS:

View data

-- Year-To-Date Accomplishments: Over the course of the year management has orchestrated a diversified umbrella of companies through various acquisitions including a minority stake in VFG Securities Incorporated, a full service broker dealer, and VFG Advisor, an RIA firm with $170-million in Assets Under Management. Additionally OCFN formed Omega Capital Street to operate as OCFN's direct balance sheet lender to originate commercial real estate, CMBS style senior-mortgages, bridge and mezzanine loans, and participating equity loans within the United States and globally. OCFN continued the expansion of its lending platform through purchasing a factoring franchise operating as Omega Factoring LLC with a bank credit facility intact for prudent leverage. -- Management: OCFN jointly along with its subsidiaries' management teams have 50 years of combined experience and knowledge across their respective lines of business -- Capital Structure: 328,671,998 Shares Outstanding with a float of 19,406,154 -- Industry Focus: Commercial Real Estate Finance Sector that has rebounded and forecasted to stabilize for the next 10-yrs -- Industry Value: Trillions of dollars of domestic and global lending opportunities available at our finger tips -- Product Niche: Small Balance Loan Originations - Untapped by many national, regional, and small community banks -- Competitive Advantage: Ability to self-fund our commercial real estate lending operations through OCFN's publicly traded platform and capital market strategies. -- Core Business of Lending Subsidiary: Through our lending subsidiary Ωmega Capital Street LLC, we shall originate and manage performing commercial real estate and senior-mortgage loans within the United States Market. These market sectors include office, retail, hospitality, industrial, and multi-family types -- Our Small Cap Growth Strategy: To strategically obtain varied ownership of inter-related operating companies with built-in synergies to harvest a broad range of financial products and services for augmenting our core lending competencies to yield a top-regional financial holding company aimed and poised for eventually up listing to the American Stock Exchange. -- Long Term Investor Confidence In Our Future: 3 Private investors each invested $1-Million through a Direct Public Offering at a fixed Price of $0.10 per share

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Summit Tackles BRI Infrastructure's Role in Global SDGs

Updated Category News Views 2

A Bold Gathering with Lofty Goals Ever watch a room of world leaders debate the finer nuances of sustainable infrastructure? That's something Singapore pulled off on September 6, 2026, with the Second Global Business Summit on Belt and Road Infrastructure Investment. These aren't just any ordinary suits sitting around in a conference room. We're talking about a dynamic...

Continue Reading
Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 1

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 3

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading
FDI Launches 'Generation Smile' for Global Oral Health

Updated Category News Views 3

A New Kind of Movement Imagine a campaign not bound by age or geography but united by a shared mission. Generation Smile, freshly launched by the FDI World Dental Federation in Prague, is just that kind of uprising. This initiative redefines existing approaches to oral health, pushing beyond the boundaries of mere dental care to emphasize the integral role oral health...

Continue Reading
Pudu D7 Robot Shines at IFA, Setting New Robotics Bar

Updated Category News Views 2

Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
ATTACK SHARK Partners with Cloud9 League Team

Updated Category News Views 2

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Continue Reading
China's Manufacturing: Squeeze or Opportunity?

Updated Category News Views 3

Analyzing China's Impact on Global Markets Think of China's manufacturing clout and you're likely to picture booming factories, relentless steel, and smoke-churning industries reshaping the global chessboard. But here's the kicker: are they swallowing up room for others, or paving the way for their growth? It’s this debate that took the spotlight at the Asia-Pacific...

Continue Reading
TCL’s AI Vision: Immersive Living at IFA 2026

Updated Category News Views 0

AI and Displays: A Match Made in Tech Heaven Every so often, a company stands up at a tech fair and gives a glimpse into the next chapter of living, as TCL did at IFA 2026. This time, they're not just talking about screens; they're weaving them into the fabric of everyday life alongside AI capabilities. From sporting arenas to your living room, it's a vision of what could...

Continue Reading

Top 5 Most Recently Viewed Articles

Anika Therapeutics Shows Recovery in Q3 2024 Performance

Updated Category News Views 46

Anika Therapeutics Reports Q3 2024 Financials In a significant move, Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in joint preservation, has reported its financial results for the third quarter ending September 30, 2024. This release follows the company’s strategic decisions to pivot its focus towards high-growth segments within the orthopedic industry. Key...

Continue Reading
Red Cat Secures $20 Million Funding for Drone Innovation

Updated Category News Views 328

Red Cat's Strategic Shift in Drone Technology Funding Red Cat Holdings, Inc. (Nasdaq: RCAT), a leader in drone technology designed for military, government, and commercial applications, has recently announced a significant financial move. The company secured an agreement for up to $20 million in debt financing, with the initial tranche of $16.5 million already completed....

Continue Reading
Investing in Alamos Gold: A 5-Year Performance Review

Updated Category News Views 84

Understanding Alamos Gold's Investment Potential Alamos Gold (NYSE: AGI) has shown impressive performance in the market over the past five years, boasting an annualized return of 27.3%. This strong growth has allowed the company to outperform the market by a significant margin of 12.72% annually. With a current market capitalization of approximately $8.42 billion, Alamos...

Continue Reading
Explore Phemex's Revolutionary 24/7 Futures Trading Hub

Updated Category News Views 135

Phemex Launches 24/7 TradFi Futures Trading Phemex, a user-focused cryptocurrency exchange, has recently announced an exciting development in trading: the introduction of their traditional finance (TradFi) futures trading. This innovative offering allows users to access a variety of traditional financial assets, including stocks and precious metals, at any time of the day...

Continue Reading
Kraig Biocraft Laboratories Announces New Production Milestone

Updated Category News Views 64

Kraig Biocraft Laboratories Reaches Remarkable Production Goal Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) has recently made headlines by completing a noteworthy production cycle that resulted in the delivery of over one million BAM-1 Alpha hybrid eggs. This significant achievement marks a pivotal moment for the company as they look to amplify their production...

Continue Reading